Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Company dossier
Sun Pharmaceutical
NSE:SUNPHARMA · ISIN INE044A01036
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sun Pharmaceutical
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Update On NidlegyBSE · exchange filing · pdf
Source filing Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Archived filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Sun Pharmaceutical Industries LimitedNSE · conference call · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Archived filing Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026BSE · financial results · pdf
Source filing Investor Presentation - Sun Pharmaceutical Industries LimitedNSE · investor presentation · pdf
Source filing Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Archived filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Shareholders meeting - Sun Pharmaceutical Industries LimitedNSE · annual report · pdf
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Notice Of 34Th Annual General Meeting To Be Held On 31 July 2026 Along With The Annual Report For FY 2025-26BSE · annual report · pdf
Archived filing Sun Pharmaceutical Industries Ltd - 524715 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Trading Window - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015BSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Intimation Of Record Date For The Purpose Of Final Dividend For FY 2025-26BSE · corporate action · pdf
Source filing Record Date - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Intimation Of 34Th Annual General Meeting And Record Date For Final Dividend And Connected MattersBSE · corporate action · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Sun Pharmaceutical Industries LimitedNSE · conference call · pdf
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing